respiratori
infect
constitut
major
public
health
problem
due
high
incid
rate
mortal
welldocu
healthcar
econom
burden
brydak
nitschosuch
et
al
fifti
eighti
percent
acut
respiratori
infect
viral
one
nitschosuch
et
al
multiplex
rtpcr
method
highli
sensit
altern
diagnost
procedur
templeton
et
al
save
time
reagent
necessari
test
sampl
presenc
genet
materi
respiratori
virus
also
expedit
introduct
proper
treatment
et
al
method
enabl
detect
sever
coinfect
contagion
singl
test
common
respiratori
virus
influenza
viru
type
b
respiratori
syncyti
viru
parainfluenza
virus
type
human
rhinoviru
human
metapneumoviru
adenoviru
human
coronaviru
et
al
influenza
diseas
due
constant
evolut
caus
persist
epidem
less
frequent
pandem
brydak
coinfect
influenza
virus
may
induc
reassort
virus
lead
pathogen
subtyp
liu
et
al
particular
coinfect
differ
subtyp
influenza
viru
constitut
like
sourc
reassort
acquir
unpredict
properti
pajak
et
al
section
structur
influenza
viru
genom
bring
variat
genotyp
phenotyp
viru
host
cell
infect
one
strain
virus
equip
new
set
gene
may
appear
consid
essenti
role
coinfect
spread
sever
diseas
goal
studi
determin
frequenc
crisscross
pattern
coinfect
influenza
influenzalik
virus
studi
protocol
approv
institut
ethic
committe
total
influenza
season
poland
sampl
patient
age
test
swab
nose
throat
wash
bronchial
tree
balf
taken
specimen
test
depart
influenza
research
nation
influenza
center
nation
institut
public
health
nation
institut
hygien
voivodeship
sanitari
epidemiolog
station
poland
sampl
prior
analysi
store
clinic
specimen
collect
week
week
week
octob
august
rna
respiratori
virus
clinic
specimen
isol
use
maxwel
viral
total
nucleic
acid
purif
kit
promega
corpor
madison
wi
sampl
suspend
pb
accord
manufactur
instruct
rna
suspend
rnasefre
water
test
perform
use
quantit
polymeras
chain
reaction
rtpcr
analysi
carri
roch
light
cycler
system
qrtpcr
reaction
perform
capillari
tube
volum
primer
probe
reaction
probe
primer
obtain
influenza
reagent
resourc
irr
program
oper
center
diseas
control
prevent
cdc
reaction
mixtur
contain
reaction
buffer
bsa
rnase
free
water
super
taq
mix
addit
rna
sampl
posit
control
consist
rna
strain
compon
influenza
vaccin
season
neg
control
provid
rnasefre
water
start
amplif
viral
rna
rewritten
cdna
use
revers
transcriptas
enzym
min
sampl
analyz
accord
follow
scheme
initi
min
cycl
amplif
denatur
anneal
extens
min
sampl
test
use
ace
detect
kit
seegen
seoul
south
korea
enabl
detect
respiratori
virus
influenza
type
b
adenoviru
adv
human
respiratori
syncyti
viru
b
rsv
b
human
coronaviru
hcov
human
metapneumoviru
hmpv
rhinoviru
ab
rvab
human
coronaviru
hcov
parainfluenza
type
random
hexamerprim
cdna
synthesi
product
gener
use
first
strand
cdna
synthesi
kit
fermenta
york
uk
accord
manufactur
instruct
cdna
prepar
subject
pcr
procedur
accord
manufactur
instruct
seegen
seoul
south
korea
reaction
product
detect
use
agaros
gel
electrophoresi
influenza
season
coinfect
influenza
virus
report
shown
tabl
follow
type
coinfect
confirm
subtyp
subtyp
case
subtyp
subtyp
case
subtyp
influenza
viru
b
type
case
subtyp
influenza
type
b
case
coinfect
unsubtyp
type
type
b
viru
case
coinfect
report
peopl
age
month
year
age
coinfect
caus
influenza
virus
report
among
children
year
age
case
agegroup
number
coinfect
lower
year
case
year
case
year
case
year
case
year
case
year
age
case
tabl
epidem
season
coinfect
influenza
virus
influenzalik
virus
among
influenzalik
virus
note
shown
tabl
seventeen
case
coinfect
influenza
influenzalik
virus
record
follow
type
coinfect
confirm
subtyp
rsv
case
rsv
rv
ab
case
influenza
type
b
viru
rsv
case
hcov
case
influenza
type
b
viru
hcov
case
influenza
type
b
viru
hmpv
rsv
case
influenza
viru
type
rsv
case
influenza
viru
type
hcov
case
influenza
viru
type
rv
ab
case
furthermor
six
coinfect
influenzalik
virus
confirm
rsv
hcov
case
rsv
rvab
case
rsv
case
adv
hcov
case
hcov
rsv
case
tabl
concern
region
distribut
coinfect
caus
anoth
influenza
viru
observ
provinc
mazovia
case
lesserpoland
case
coinfect
one
influenza
viru
note
subcarpathian
case
lowersilesia
case
singl
case
kuyavianpomeranian
silesia
lublin
provinc
tabl
coinfect
subtyp
subtyp
influenza
b
viru
confirm
provinc
mazovia
case
respect
coinfect
subtyp
influenza
b
viru
report
mazovia
case
subcarpathian
lesserpoland
case
lowersilesia
kuyavianpomeranian
lublin
provinc
case
frequent
confirm
coinfect
combin
infect
influenza
viru
type
b
case
report
mazovia
lesserpoland
provinc
moreov
subcarpathian
silesia
lowersilesia
provinc
one
case
confirm
per
region
tabl
epidem
season
domin
coinfect
unsubtyp
influenza
b
viru
case
report
among
peopl
year
age
also
case
subtyp
influenza
viru
type
b
coinfect
moreov
detect
singl
case
coinfect
subtyp
influenza
viru
type
b
year
age
subtyp
year
age
also
four
confirm
case
coinfect
subtyp
among
children
year
age
adult
year
age
coinfect
influenza
virus
influenzalik
virus
coinfect
among
influenzalik
virus
report
children
year
age
follow
coinfect
detect
subtyp
influenza
type
b
viru
hmpv
rsv
year
age
also
four
case
coinfect
three
respiratori
virus
three
case
coinfect
subtyp
rsv
rv
ab
one
case
coinfect
subtyp
influenza
type
b
viru
hcov
tabl
epidem
season
higher
number
confirm
coinfect
influenza
respiratori
influenzalik
virus
compar
previou
season
season
coinfect
follow
ten
subtyp
type
b
viru
czarkowski
et
al
season
coinfect
follow
two
subtyp
seven
influenza
influenzalik
virus
two
influenza
type
viru
rsv
viru
rv
ab
viru
oneday
old
onemonthold
children
three
influenzalik
virus
bednarska
et
al
season
framework
imov
influenza
monitor
vaccin
effect
program
follow
coinfect
detect
seven
subtyp
type
b
viru
eight
subtyp
type
b
viru
last
season
addit
one
coinfect
influenza
virus
four
influenza
virus
influenzalik
virus
note
children
year
age
et
al
signific
increas
number
infect
one
respiratori
viru
season
could
associ
higher
number
sampl
test
sampl
compar
two
preced
season
sampl
respect
bednarska
et
al
bednarska
et
al
nonetheless
influenza
virus
constantli
evolv
undergo
antigen
chang
provid
abil
elud
host
immun
respons
system
webster
et
al
